APA (7th ed.) Citation

Assadi, F., & Bidabadi, E. (2025). SGLT-2 Inhibitors for the Treatment of Hyperkalemia in Children With Kidney Disease and Heart Failure Receiving Renin-Angiotensin-Aldosterone Inhibition: A Call for Data. Journal of Pediatric Pharmacology & Therapeutics, 30(6), 822. https://doi.org/10.5863/JPPT-25-00053

Chicago Style (17th ed.) Citation

Assadi, Farahnak, and Elham Bidabadi. "SGLT-2 Inhibitors for the Treatment of Hyperkalemia in Children With Kidney Disease and Heart Failure Receiving Renin-Angiotensin-Aldosterone Inhibition: A Call for Data." Journal of Pediatric Pharmacology & Therapeutics 30, no. 6 (2025): 822. https://doi.org/10.5863/JPPT-25-00053.

MLA (9th ed.) Citation

Assadi, Farahnak, and Elham Bidabadi. "SGLT-2 Inhibitors for the Treatment of Hyperkalemia in Children With Kidney Disease and Heart Failure Receiving Renin-Angiotensin-Aldosterone Inhibition: A Call for Data." Journal of Pediatric Pharmacology & Therapeutics, vol. 30, no. 6, 2025, p. 822, https://doi.org/10.5863/JPPT-25-00053.